Related Experiment Video
Updated: Sep 20, 2025

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
Published on: June 28, 2013
Generation of an induced pluripotent stem cell line from a Chinese Han child with catecholaminergic polymorphic
Wei Liu1, Ting Liu2, Tingting Xiao3
1Department of Cardiology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, No. 355 Luding Road, Shanghai 200062, China.
Insights
Researchers generated induced pluripotent stem cells (iPSCs) from a patient with catecholaminergic polymorphic ventricular tachycardia (CPVT). These iPSCs carry the TECRL mutation, offering a new tool to study CPVT mechanisms.
Area of Science:
- Cardiology
- Stem Cell Biology
- Genetics
Background:
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic heart rhythm disorder.
- The TECRL gene, encoding an endoplasmic reticulum protein, is implicated in CPVT.
- Understanding TECRL's role in cardiomyocyte calcium handling is crucial for CPVT pathogenesis.
Purpose of the Study:
- To generate a patient-specific induced pluripotent stem cell (iPSC) line from a CPVT patient with a known TECRL mutation.
- To establish a cellular model for investigating the mechanisms underlying TECRL-associated CPVT.
- To provide a valuable research platform for drug discovery and therapeutic strategies.
Main Methods:
- Generated patient-derived iPSCs using Sendiavirus-mediated reprogramming from peripheral blood mononuclear cells.
- Characterized iPSC pluripotency, differentiation capacity, and karyotype stability.
- Confirmed the presence of the pathogenic TECRL mutation in the generated iPSC line.
Main Results:
- Successfully generated a stable iPSC line from a CPVT patient.
- The iPSC line demonstrated pluripotency markers and spontaneous differentiation into three germ layers.
- The iPSC line maintained a normal karyotype and harbored the specific TECRL mutation.
Conclusions:
- Patient-derived iPSCs carrying the TECRL mutation provide a robust model for CPVT research.
- This iPSC resource facilitates the study of TECRL's function in cardiac calcium homeostasis.
- The developed cell line is instrumental for elucidating CPVT mechanisms and exploring potential therapies.
Abstract:
TECRL, first reported in a Sudanese family with catecholaminergic polymorphic ventricular tachycardia (CPVT) in 2016. TECRL, is an endoplasmic reticulum (ER) protein preferentially expressed in the heart, playing a role in cardiomyocyte calcium homeostasis. Using Sendaivirus-mediated reprogramming, we generated an induced pluripotent stem cell (iPSC) line from the CPVT patient's peripheral blood mononuclear cell. The iPSC exhibited stable amplification, expressed pluripotent markers, and differentiated spontaneously into three layers in vitro. Additionally, the iPSC line maintained a normal karyotype, retained the pathogenic TECRL mutation, and the cell resource facilitated a platform to explore the CPVT mechanisms related to TECRL mutations.
More Related Videos
11:13Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes hPSC-CMs Using Multi-electrode Arrays MEAs
Published on: May 12, 2017
08:06Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
Published on: January 17, 2020